Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 1/2017

01-01-2017 | Original Article

Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer

Authors: Faisal Aziz, Wei Gao, Qiu Yan

Published in: Pathology & Oncology Research | Issue 1/2017

Login to get access

Abstract

H. pylori cytotoxin associated antigen A (CagA) plays a significant role in the progression of gastric cancer but their effect on fucosylation to develop gastric cancer is unknown. Fucosyltransferase IV (FUT4) is the key enzyme for synthesis of LewisY (LeY) carried by glycoproteins and glycolipids on the cell membrane. Herein, we compare the expression of CagA, p-EGFR, FUT4 and LeY in gastritis (n = 128, 176), gastric ulcer (n = 174, 213), and gastric cancer (n = 323, 261) tissue and serum samples, respectively by IHC and ELISA. Moreover, we investigated the potential correlation of CagA with FUT4 and LeY overexpression through EGFR activation. IHC and ELISA results showed higher positive cases of H. pylori CagA (83, 86 %), p-EGFR (81, 72 %), FUT4 (91, 97 %) and LeY (93, 92 %) in gastric cancer, compared to gastritis and gastric ulcer, H. pylori CagA (58, 67 & 59, 73 %), p-EGFR (52, 63 & 35, 47 %), FUT4 (68, 78 & 67, 82 %) and LeY (62,76 & 65, 85 %), respectively. We found a significant high expression (H-Value) of CagA (1.79, 1.66), p-EGFR (1.53, 1.58), FUT4 (2.14, 1.66) and LeY (1.69, 1.61) in gastric cancer tissues and serum, respectively as compared to chronic gastritis and gastric ulcers, CagA (0.64,1.14), p-EGFR (0.856, 0.678), FUT4 (0.949,1.197) and LeY (0.68,1.008) (P < 0.0001), respectively. Furthermore, H. pylori CagA showed significant correlation with p-EGFR (R–0.62, −0.74), FUT4 (R–0.81, −0.76) and LeY (R–0.82, −0.70) in gastric tissues and serum (P < 0.0001). H. pylori CagA plays key role in the development of gastric cancer with overexpression of FUT4/LeY, serve as potentially correlative biomarkers of H. pylori CagA associated gastric cancer.
Literature
1.
Aziz F, Sherwani SK, Akhtar SS, Kazmi SU (2014a) Development of an in-house enzyme-linked immunosorbent assay based on surface whole cell antigen for diagnosis of helicobacter pylori infection in patients with gastroduodenal ulcer disease. World J Microbiol Biotechnol 30:305–315CrossRefPubMed
2.
Zhu Y, Zhong X, Zheng S, Du Q, Xu W (2005) Transformed immortalized gastric epithelial cells by virulence factor cagA of helicobacter pylori through Erk mitogen-activated protein kinase pathway. Oncogene 24:3886–3895CrossRefPubMed
3.
Aziz F, Taj Y, Kazmi SU (2013b) In-house enzyme-linked immunosorbent assay based on helicobacter pylori sonicate whole cell antigen for diagnosis of helicobacter pylori infection in Karachi. Pakistan Int J Microbiol Adv Immunol 1(4):24–31
4.
Aziz F, Chen X, Yang X, Yan Q (2014b) Prevalence and correlation with clinical diseases of helicobacter pylori cagA and vacA genotype among gastric patients from Northeast China. Biomed Res Int 2014:142980PubMedPubMedCentral
5.
Yamaoka Y (2008) Increasing evidence of the role of helicobacter pylori SabA in the pathogenesis of gastroduodenal disease. J Infect Dev Ctries 1:174–181
6.
Hatakeyama M, Higashi H (2005) Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci 96:835–843CrossRefPubMed
7.
Asahi M, Azuma T, Ito S, Ito Y, Suto H, Nagai Y et al (2000) Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 191:593–602CrossRefPubMedPubMedCentral
8.
Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, Haas R (2000) Translocation of helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497–1500CrossRefPubMed
9.
Menaker RJ, Ceponis PJ, Jones NL (2004) Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway. Infect Immun 72:2889–2898CrossRefPubMedPubMedCentral
10.
De la Cruz-Herrara CF, Flores-Luna L, Guterrez-Xicotencatl L, Chihu-Amparan L, Sanchez-Aleman MA, Lazcano-Ponce E, Torres J, Ayala G (2013) IgG2 response and low IgG titer specific to helicobacter pylori CagA as serological markers for gastric cancer. J Med Microbiol 62:591–598CrossRef
11.
Aziz F, Wang X, Liu J, Yan Q (2016) Ginsenoside Rg3 induces FUT4-mediated apoptosis in H. Pylori CagA-treated gastric cancer cells by regulating SP1 and HSF1 expressions. Toxicol in Vitro 31:158–166CrossRefPubMed
12.
Moran AP, Gupta A, Joshi L (2011) Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut 60:1412–1425CrossRefPubMed
13.
Reis CA, Osorio H, Silva L, Gomes C, David L (2010) Alteration in glycosylation as biomarkers for cancer detection. J Clin Pathol 63:322–329CrossRefPubMed
14.
Delmotte P, Degroote S, Lafitte JJ, Lamblin G, Perini JM, Roussel P (2002) Tumor necrosis factor alpha increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa. J Biol Chem 277:424–431CrossRefPubMed
15.
Miyoshi E, Moriwaki K, Nakagawa T (2008) Biological function of fucosylation in cancer biology. J Biochem 14:725–729
16.
17.
Yang X, Zhang Z, Jia S, Liu Y, Wang X, Yan Q (2007) Overexpression of fucosyltransferase IV in A431 cell line increase cell proliferation. Int J Biochem Cell Biol 39:1722–1730CrossRefPubMed
18.
Sheu BS, Sheu SM, Yang HB, Huang AH, Wu JJ (2003) Host gastric Lewis expression determines the bacterial density of helicobacter pylori in babA2 genopositive infection. Gut 52:927–932CrossRefPubMedPubMedCentral
19.
Wang XQ, Zhu ZM, Fenderson BA, Zeng GQ, Cao YJ, Jiang GT (1998) Effects of monoclonal antibody directed to LeY on implantation in the mouse. Mol Hum Reprod 4:295–300CrossRefPubMed
20.
Dettke M, Palfi G, Pursch E, Fischer MB, Loibner H (2001) Increased expression of the blood group-related Lewis Y antigen on synovial fluid granulocytes of patients with arthritic joint diseases. Rheumatology (Oxford) 40:1033–1037CrossRef
21.
Madjd Z, Parsons T, Watson NF, Spendlove I, Ellis I, Durrant LG (2006) High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Res 7:80–87
22.
Aziz F, Yang X, Wang X, Yan Q (2014c) Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study. J Cancer Res Clin Oncol 141(7):1221–1235CrossRefPubMed
23.
Aziz F, Qiu Y (2014) The role of anti-LeY antibody in the downregulation of MAPKs/COX-2 pathway in gastric cancer. Curr Drug Targets 15:469–476CrossRefPubMed
24.
Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, Qiao YL, Inoue M (2011) Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol 17:4421–4428CrossRefPubMedPubMedCentral
25.
Björkholm B, Falk P, Engstrand L, Nyrén O (2003) Helicobacter pylori: resurrection of the cancer link. J Intern Med 253:102–119CrossRefPubMed
26.
Figueroa G, Troncoso M, Toledo MS, Faúndez G, Acuña R (2002) Prevalence of serum antibodies to helicobacter pylori VacA and CagA and gastric diseases in Chile. J Med Microbiol 51:300–304CrossRefPubMed
27.
Khan A, Farooqui A, Raza Y, Rasheed F, Manzoor H, Akhtar SS, Quraishy MS, Rubino S, Kazmi SU, Paglietti B (2013) Prevalence, diversity and diseases association of helicobacter pylori in dyspeptic patients from Pakistan. J Infect Dev Ctries 7:220–228CrossRefPubMed
28.
Liu JJ, Lin B, Hao YY, Li FF, Liu DW, Qi Y, Zhu LC, Zhang SL, Iwamori M (2010) Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathways. Oncol Rep 23:833–841CrossRefPubMed
29.
Keates S, Sougioultzis S, Keates AC, Zhao D, Peek RM Jr, Shaw LM, Kelly CP (2001) cag + Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Biol Chem 276:48127–48134CrossRefPubMed
30.
Zhang Z, Sun P, Liu J, Fu L, Yan J, Liu Y, Yu L, Wang X, Yan Q (2008) Suppression of FUT1/FUt4 expression by SiRNA inhibits tumor growth. Biochim Biophys Acta 1783:287–296CrossRefPubMed
31.
Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Borén T (1998) Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373–377CrossRefPubMed
32.
Kudo T, Ikehara Y, Togayachi A, Morozumi K, Watanabe M, Nakamura M et al (1998) Up-regulation of a set of glycosyltransferases genes in human colorectal cancer. Lab Investig 78:797–711PubMed
33.
Saito H, Hiraiwa N, Sawada-Kasugai M, Akamatsu S, Tachikawa T, Kasai Y et al (1997) Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. Int J Cancer 71:556–564CrossRef
34.
Taniguchi A, Suga R, Matsumoto K (2002) Expression and transcriptional regulation of the human alpha1,3-fucosyltransferase 4 (FUT4) gene in myeloid and colon adenocarcinoma cell lines. Biochem Biophys Res Commun 273(1):370–376CrossRef
35.
Martin-Satue M, Marrugat R, Cancelas JA, Blanco J (1998) Enhanced expression of α1,3-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastastic potential of human lung adnocarcinoma cells. Cancer Res 58:1544–1550PubMed
36.
Yan X, Lin Y, Liu S (2015) Faisal Aziz, Qiu Yan, fucosyltransferase IV (FUT4) as an effective biomarker for the diagnosis of breast cancer. Biomed Pharmacother 70:299–304CrossRefPubMed
37.
Dohi T, Abe K, Ohshiba S (1989) Immunohistochemical study of carbohydrate antigen expression in gastric carcinoma. Gastroenterol Jpn 24:239–245PubMed
38.
Sakamoto S., Watanabe T., Tokumaru T., Takagi H., Nakazato H. and Lloyd K.O (1989) Expression of Lewisa, Lewisb, Lewisx, Lewisy, siayl-Lewisa, and sialyl-Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res 49:745–752.
39.
Kobayashi K, Sakamoto J, Kito T, Yamamura Y, Koshikawa T, Fujita M, Watanabe T, Nakazato H (1993) Lewis blood group-related antigen expression in normal gastric epithelium, intestinal metaplasia, gastric adenoma, and gastric carcinoma. Am J Gastroenterol 88:919–924PubMed
40.
Escrevente E, Machado C, Brito CA, Reis A, Stoeck S, Runz A, Marme P, Altevogt JC (2006) Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines. Int J Oncol 29:557–566PubMed
41.
Wirth HP, Yang M, Karita M, Blaser MJ (1990) Expression of human cell surface glycoconjugates Lewis x and Lewis y by helicobacter pylori isolates is related to CagA status. Infect Immun 64:4598–4605
42.
Aziz F, Yang X, Wang X, Qiu Y (2013a) Helicobacter pylori infection leads to gastric cancer with the coexpression of Lewis Y and CA724. Glycoconj J 30:411
43.
Aziz F, Yang X, Wen Q, Qiu Y (2015) A method for establishing human primary gastric epithelial cell culture from fresh surgical gastric tissues. Mol Med Rep 12(2):2939–2944PubMed
44.
Gomes C, Almeida A, Ferreira JA, Silva L, Santos-Sousa H, Pinto-de-Sousa J, Santos LL, Amado F, Schwientek T, Levery SB, Mandel U, Clausen H, David L, Reis CA, Osório H (2013) Glycoproteomics analysis of serum from patients with gastric precancerous lesions. J Proteome Res 12:1454–1466CrossRefPubMed
Metadata
Title
Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer
Authors
Faisal Aziz
Wei Gao
Qiu Yan
Publication date
01-01-2017
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 1/2017
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-016-0122-1

Other articles of this Issue 1/2017

Pathology & Oncology Research 1/2017 Go to the issue

Original Article

Negative Regulatory Role of TWIST1 on SNAIL Gene Expression

Original Article

Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer

Original Article

Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer

Original Article

May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?

Original Article

The Promoting Effect of Radiation on Glucose Metabolism in Breast Cancer Cells under the Treatment of Cobalt Chloride

Letter to the Editor

Spermatocytic Seminoma with Brain Metastasis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits